Standard Life Aberdeen sells insurance arm to Phoenix for £3bn

Retains platform and financial advice business

Jenna Towler
clock • 3 min read

Standard Life Aberdeen has sold its insurance business to Phoenix Group in a £3bn deal.

Standard Life Aberdeen will retain its adviser platforms Wrap, Elevate and Parmenion and financial advice business 1825.  The sale sees the disposal of Standard Life Assurance with the transfer of the UK mature retail and spread/risk books to Phoenix. It has also disposed of the Europe, UK retail and workplace businesses, an announcement to the stock exchange said.  On completion Standard Life Aberdeen will receive total consideration of £3.24bn, comprising cash consideration of £2.28bn and a shareholding of 19.99% in Phoenix Group. Standard Life Aberdeen chairman Gerry Grimstone s...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Your profession

Feel Good Friday: Quilter pledges £3m towards financial education

Feel Good Friday: Quilter pledges £3m towards financial education

Alongside £1m in grants supporting charities

Professional Adviser
clock 13 February 2026 • 1 min read
Brits unlikely to see IFAs despite Budget impact

Brits unlikely to see IFAs despite Budget impact

Just 19% were likely to seek advice, Continuum finds

Isabel Baxter
clock 12 February 2026 • 3 min read
Treasury consults on AR regime adding further FCA and FOS permissions

Treasury consults on AR regime adding further FCA and FOS permissions

Amid concerns about consumer harm and weaknesses in oversight

Isabel Baxter
clock 12 February 2026 • 3 min read